Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.

Harousseau, Jean-Luc;Avet-Loiseau, Herve;Attal, Michel;Charbonnel, Catherine;Moreau, Philippe;et.al.
(2009) Journal of clinical oncology : official journal of the American Society of Clinical Oncology — Vol. 27, n° 34, p. 5720-5726 (2009)

Files

HarousseauJLetalJClinOncol2009.pdf
  • Restricted Access
  • Adobe PDF
  • 271.88 KB
No access

Details

Authors
  • Harousseau, Jean-Luc
    Author
  • Avet-Loiseau, Herve
    Author
  • Attal, Michel
    Author
  • Charbonnel, Catherine
    Author
  • Moreau, Philippe
    Author
Show more
Abstract
In the context of ASCT, achievement of at least VGPR is a simple prognostic factor that has importance in intermediate and high-risk MM and can be informative in more patients than CR.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Harousseau, J.-L., Avet-Loiseau, H., Attal, M., Charbonnel, C., Garban, F., Hulin, C., Michallet, M., Facon, T., Garderet, L., Marit, G., Ketterer, N., Lamy, T., Voillat, L., Guilhot, F., Doyen, C., Mathiot, C., & Moreau, P. (2009). Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27(34), 5720-5726. https://doi.org/10.1200/JCO.2008.21.1060 (Original work published 2009)